Talzenna .5 mg/1
talazoparib · CAPSULE, LIQUID FILLED · U.S. Pharmaceuticals
Talzenna is a capsule, liquid filled containing talazoparib at .5 mg/1, taken oral. Manufactured by U.S. Pharmaceuticals.
Key Facts
- Brand Name
- Talzenna
- Generic Name
- talazoparib
- NDC Code (Product)
63539-025- Manufacturer
- U.S. Pharmaceuticals
- Strength
- .5 mg/1
- Dosage Form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Marketing Status
- Application #
- NDA217439
- Marketing Start
- 07/09/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Talzenna used for?
Talzenna contains talazoparib. It is a capsule, liquid filled taken oral. Consult your doctor for specific uses.
Is Talzenna a controlled substance?
Talzenna is not classified as a controlled substance by the DEA.
What is the generic name for Talzenna?
The generic name for Talzenna is talazoparib. There are no other listed brand versions of talazoparib.
What is the NDC code for Talzenna .5 mg/1?
The NDC (National Drug Code) for Talzenna .5 mg/1 is 63539-025, listed by U.S. Pharmaceuticals.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)